<DOC>
	<DOCNO>NCT00890500</DOCNO>
	<brief_summary>The purpose research study determine safety efficacy reduce intensity condition regimen double umbilical cord blood unit transplant one cord blood unit modulate ProHema .</brief_summary>
	<brief_title>Safety Efficacy ProHema Modulated Umbilical Cord Blood Units Subjects With Hematologic Malignancies .</brief_title>
	<detailed_description>The purpose research study determine safety efficacy reduce intensity condition regimen double umbilical cord blood unit transplant one cord blood unit modulate ProHema . -As part research study cord unit modulate laboratory ProHema give participant . Two different treatment group test . Group 1 : second cord blood unit modulate ProHema ; Group 2 : first cord blood unit modulate ProHema .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Antilymphocyte Serum</mesh_term>
	<mesh_term>Melphalan</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<criteria>Patients hematologic malignancy allogeneic stem cell transplantation deem clinically appropriate Patient must ineligible traditional myeloablative transplantation accord treat physician Lack 6/6 5/6 HLAmatched relate , 8/8 HLAmatched unrelated donor , unrelated donor available within time frame necessary perform potentially curative stem cell transplant 1865 year age ECOG Performance Status 02 The following hematologic malignancy exclude : Myelofibrosis unless exposure cytotoxic chemotherapy treatment progression acute myeloid leukemia Chronic Myelogenous Leukemia , unless exposure cytotoxic chemotherapy treatment blast phase , 3 ) Aplastic anemia , absence transformation Myelodysplastic disorder Cardiac disease : symptomatic congestive heart failure evidence leave ventricular dysfunction measure gated radionucleotide ventriculogram echocardiogram ; active angina pectoris , uncontrolled hypertension Pulmonary disease : symptomatic chronic obstructive lung disease , symptomatic restrictive lung disease , correct DLCO &lt; 50 % predict , correct hemoglobin Renal disease : serum creatinine &gt; 2.0mg/dl Hepatic disease : serum bilirubin &gt; 2.0mg/dl ( expect case Gilbert 's syndrome ongoing hemolytic anemia ) , SGOT SGPT &gt; 3 x upper limit normal Neurologic disease : symptomatic leukoencephalopathy , active CNS malignancy neuropsychiatric abnormality believe preclude transplantation HIV antibody Uncontrolled infection Pregnancy breast feed mother Inability comply requirement care allogeneic stem cell transplantation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>